• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Netherlands·Industrials·AALB.AS
Share

Aalberts N.V. Stocks

€ 40.46Last Updated 23.10.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

€ 4.98B

€ 40.46
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Aalberts N.V. develops essential, high-performance technologies. The company is structured into two main divisions: Building Technology and Industrial Technology. The Building Technology segment focuses on creating, manufacturing, and monitoring hydronic flow control systems to optimize energy efficiency in heating and cooling. This division also designs and produces integrated piping systems for the precise distribution and regulation of water or gas in heating, cooling, water, gas, and sprinkler networks, serving eco-friendly construction and specialized industrial settings. The Industrial Technology segment partners with original equipment manufacturers (OEMs) to engineer and produce advanced mechatronics and technologies. These solutions are vital for the accurate regulation, measurement, and control of fluids under challenging and critical circumstances, benefiting areas such as semiconductor efficiency, sustainable transport, and various industrial applications. Furthermore, this division provides a range of surface treatment technologies, utilizing a network of local service centers to support customers in the sustainable transportation and industrial sectors. Aalberts N.V. has a significant global footprint, with operations across Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific region, the Middle East, and Africa. Founded in 1975 and based in Utrecht, the Netherlands, the company rebranded from Aalberts Industries N.V. to its current name in April 2019.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of AALB.AS is 47.7 and suggests 17.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026